Hepatitis B virus reactivation or reinfection in a FEM-PrEP participant: a case report

INTRODUCTION: The FEM-PrEP trial was a pre-exposure prophylaxis clinical trial to test the safety and efficacy of Truvada (tenofovir disoproxil fumarate and emtricitabine) in the prevention of human immunodeficiency virus infection. Because Truvada can suppress hepatitis B virus replication, and wit...

Descripción completa

Detalles Bibliográficos
Autores principales: Malahleha, Mookho, Ahmed, Khatija, Deese, Jennifer, Nanda, Kavita, van Damme, Lut, De Baetselier, Irith, Burnett, Rosemary J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4586016/
https://www.ncbi.nlm.nih.gov/pubmed/26411737
http://dx.doi.org/10.1186/s13256-015-0679-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4586016/
https://www.ncbi.nlm.nih.gov/pubmed/26411737
http://dx.doi.org/10.1186/s13256-015-0679-4

Ejemplares similares